[{"id":"6a3ca27a-1595-4d7e-8c01-bc48d9134717","acronym":"GB261-001","url":"https://clinicaltrials.gov/study/NCT04923048","created_at":"2021-06-11T18:56:10.085Z","updated_at":"2024-07-02T16:35:47.529Z","phase":"Phase 1/2","brief_title":"A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.","source_id_and_acronym":"NCT04923048 - GB261-001","lead_sponsor":"Genor Biopharma Co., Ltd.","biomarkers":" CD20","pipe":"","alterations":" ","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CND261"],"overall_status":"Recruiting","enrollment":" Enrollment 460","initiation":"Initiation: 08/31/2021","start_date":" 08/31/2021","primary_txt":" Primary completion: 06/28/2024","primary_completion_date":" 06/28/2024","study_txt":" Completion: 06/28/2025","study_completion_date":" 06/28/2025","last_update_posted":"2023-05-22"}]